Investors

Novartis boosts value chain for stakeholders, embeds ESG in core business operations

By embedding environmental, social and governance (ESG) topics into core business strategy and operations, Novartis aims to build trust with society and deliver long-term value to stakeholders. In February, the company released its first Novartis in Society Integrated Report 2021, marking a new approach to reporting which describes how it creates value for stakeholders through its purpose of reimagine medicine to improve and extend people’s lives. As a case in point, in 2021, Novartis’ medicines reached 766 million patients pf which 56.2 patients were reached through its various access-to-medicine approaches. This report is intended for all Novartis stakeholders, and it complies with specific requirements of investors and ESG professionals.

Thirty Years At A Glance

“We must all recognize the power of our investable dollars to accelerate the transition to a just and sustainable global economy that ensures a livable planet for all of us”, said Lubber, C.E.O and President Ceres.

The Top 10 Highest Return Industries

Speculators in stock exchanges by and large search for the most noteworthy returns – which speculations can profit at a given level of danger. It’s the same with proprietors of secretly held firms. Outside financial specialists choose whether they can profit putting resources into privately owned business A than in organization B. An entrepreneur, as well, measures the measure of benefit an organization is producing in respect to what they’ve put into the business.